Peptide Therapeutics Market – Insights
Peptides are the efficacious and selective signaling molecules, which bind with particular surface receptors of cell for triggering intracellular effects.
The global peptide therapeutics market is estimated to value for US$ 23,319.3 Mn and is projected to generate US$ 57,166.5 Mn by the end of 2027.
Get Your FREE Sample Copy of the Peptide Therapeutics Market Report 2021
Global Peptide Therapeutics Market: Drivers
Increasing incidence of cardiovascular disorders (CVDs) and metabolic diseases is expected to drive the global peptide therapeutics market growth during the forecast period. For instance, as per the American Heart Association’s Heart Disease and Stroke Statistics 2018, over 92.1 Mn adults are having from some kind of CVD or the stroke’s after-effects, in the U.S.
Furthermore, increasing expenditure for healthcare is expected to fuel in growth the global peptide therapeutics market growth during the forecast period. For instance, as per the Centers for Medicare & Medicaid Services (CMS), the U.S. health spending is expected to expand at an average 5.5% /year rate during 2018-27 and reach around US$ 6.0 Tn by 2027.
North America accounted for the largest market share, in 2018, in the global peptide therapeutics market, valuing for a share of 42.1% preceding Europe.
Global Peptide Therapeutics Market: Restraints
Poor physical and chemical stability along with short half-life of circulating plasma from naturally occurring peptides is expected to restrain the global peptide therapeutics market growth over the forecast period.
Moreover, strict safety regulations are also is expected to restrain the global peptide therapeutics market growth over the forecast period. Pharmaceuticals products including peptide therapeutics need better regulatory framework since they treat various pathological conditions; regulatory frameworks is expected to be improved by 2020.
View Press Release For More Information
Global Peptide Therapeutics Market: Opportunities
R&D in novel peptides is projected to provide opportunities for lucrative growth for the market players. For instance, CohBar, Inc. in December 2019, announced novel preclinical data, confirming therapeutic potential of the new CohBar peptide within the Idiopathic Pulmonary Fibrosis’s (IPF) preclinical model.
Furthermore, R&D for microbiome is expected to drive the global peptide therapeutics market growth in the near future. Researchers at The Chaim Sheba Medical Center, Israel, in January 2020, recorded that high consumption of fructose influenced dysbiosis and metabolic changes in rats and those metabolic changes potentially are independent of a particular microbiome profile.
Parenteral sub-segment in the segment of route of administration in global peptide therapeutics market accounted for US$ 16,416.8 Mn in 2018 and is projected to generate US$ 40,790.6 Mn by 2027 at a CAGR of 10.5% over the forecast period.
Market Trends/Key Takeaways
The global peptide therapeutics market is witnessing rising adoption of novel platforms developing next-generation peptide or protein therapeutics. For instance, Xenetic Biosciences, Inc., in January 2020, announced the data publication from its completed clinical study of Phase 1/2 for SHP656 (“PSA-recombinant Factor VIII”, “PSA-rFVIII”) within the Haemophilia journal. The study utilized PolyXen technology by Xenetic – a platform technology which is patent-protected to create next-gen peptide or protein therapeutics.
The global peptide therapeutics market is even witnessing rising activities of M&A. For instance, Almirall, S.A., in January 2020, acquired the Bioniz Therapeutics Inc., a biopharmaceutical firm in clinical stage which develops first-in-class treatments of peptide for the immuno-inflammatory diseases.
Reasons to Purchase this Report
• Current and future of global Peptide Therapeutics market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Buy Now This Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/1837
“Limited Time Offer”
Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/1837
Regulations
U.S.
- As per the FDC and PHS act of the U.S. FDA, CDER and CBER are responsible for certain part of therapeutic proteins
- CDER now has regulatory role, which includes premarket review and continuing oversight of therapeutic peptides
- 2012: As per FDA, ‘peptides are defined as any alpha amino acid polymer with specific defined sequence that is 40 amino acids or less in size’.
- Since there are various peptide conjugate candidates that contain peptides in combination with small molecules, the regulatory aspect for peptide is still evolving
- The FDA takes into account the history and manufacturing aspect of the candidate molecule to decide its regulatory pathway Example whether BLA would be submitted or NDA needs to be applied
- All the non-clinical studies are carried out as per ICH-S6 guidelines
Global Peptide Therapeutics Market: Competitive Landscape
Key players functioning in the global peptide therapeutics market are, AstraZeneca plc, CordenPharma International, Bachem Holding AG, Eli Lilly and Company, Merck & Co., Inc., Ipsen S.A, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd, and PolyPeptide Group.
Global Peptide Therapeutics Market: Key Developments
Major market players are focusing on adoption of collaboration strategies for expanding their portfolio of products. For instance, PolyPeptide Group, in October 2019, in collaboration with Enabling Technologies Team from IBMM (Institut des Biomolécules Max Mousseron) and the Green Chemistry, for R&D in greener solutions for producing synthetic peptides.
Major market players are focusing on adoption of M&A strategies for expanding their portfolio of products. For instance, Xenetic Biosciences, Inc., in July 2019, completed acquisition of new platform technology of CAR T (“Chimeric Antigen Receptor T Cell”), named “XCART,” designed for using screening technique for identifying peptide ligands which specifically bind with the malignant tumor cell’s novel B-cell receptor.
Ask for PDF sample copy of the Peptide Therapeutics market report @ https://www.coherentmarketinsights.com/insight/request-pdf/1837
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Type
- Market Snippet By Application
- Market Snippet By Route of Administration
- Market Snippet By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Market Trends
- Epidemiology
- Merger and Acquisitions
- New Product Approvals/Launch
- Pipeline Analysis
- PEST Analysis
- Market Dynamics
- Global Peptide Therapeutics Market, By Type, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Branded Peptide
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Generic Peptide
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Peptide Therapeutics Market, By Application, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Cancer
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 – 2026
- Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Metabolic Disease
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Infectious Disease
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Peptide Therapeutics Market, By Route of Administration, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Oral Administration
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Parenteral Administration
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Peptide Therapeutics Market, By Regions, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 – 2026
- Segment Trends
- North America
- Market Size and Forecast, By Type, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Type, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Type, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Type, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- Northern Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Type, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Analyst Views
- Section
- References
- Analyst Views
- Research Methodology
- About Us and Sales Contact
Other Exclusive Reports:
Chemotherapy-induced Thrombocytopenia Therapeutics Market
Central Nervous System Disorders Therapeutics Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837